Global Flu Shots Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Flu Shots market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Flu Shots market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Flu Shots market include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Flu Shots, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Flu Shots, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Shots, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Shots sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Flu Shots market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Flu Shots sales, projected growth trends, production technology, application and end-user industry.
Flu Shots Segment by Company
SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type
Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Flu Shots status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Flu Shots market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Flu Shots significant trends, drivers, influence factors in global and regions.
6. To analyze Flu Shots competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flu Shots market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flu Shots industry.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Flu Shots in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Flu Shots market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Flu Shots market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Flu Shots market include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Flu Shots, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Flu Shots, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Shots, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Shots sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Flu Shots market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Flu Shots sales, projected growth trends, production technology, application and end-user industry.
Flu Shots Segment by Company
SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type
Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Flu Shots status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Flu Shots market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Flu Shots significant trends, drivers, influence factors in global and regions.
6. To analyze Flu Shots competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flu Shots market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flu Shots industry.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Flu Shots in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
199 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Flu Shots Sales Value (2020-2031)
- 1.2.2 Global Flu Shots Sales Volume (2020-2031)
- 1.2.3 Global Flu Shots Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Flu Shots Market Dynamics
- 2.1 Flu Shots Industry Trends
- 2.2 Flu Shots Industry Drivers
- 2.3 Flu Shots Industry Opportunities and Challenges
- 2.4 Flu Shots Industry Restraints
- 3 Flu Shots Market by Company
- 3.1 Global Flu Shots Company Revenue Ranking in 2024
- 3.2 Global Flu Shots Revenue by Company (2020-2025)
- 3.3 Global Flu Shots Sales Volume by Company (2020-2025)
- 3.4 Global Flu Shots Average Price by Company (2020-2025)
- 3.5 Global Flu Shots Company Ranking (2023-2025)
- 3.6 Global Flu Shots Company Manufacturing Base and Headquarters
- 3.7 Global Flu Shots Company Product Type and Application
- 3.8 Global Flu Shots Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Flu Shots Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Flu Shots Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Flu Shots Market by Type
- 4.1 Flu Shots Type Introduction
- 4.1.1 Influenza Whole Virus Vaccines
- 4.1.2 Influenza Virus Subunit Vaccines
- 4.1.3 Influenza Virus Split Vaccines
- 4.2 Global Flu Shots Sales Volume by Type
- 4.2.1 Global Flu Shots Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Flu Shots Sales Volume by Type (2020-2031)
- 4.2.3 Global Flu Shots Sales Volume Share by Type (2020-2031)
- 4.3 Global Flu Shots Sales Value by Type
- 4.3.1 Global Flu Shots Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Flu Shots Sales Value by Type (2020-2031)
- 4.3.3 Global Flu Shots Sales Value Share by Type (2020-2031)
- 5 Flu Shots Market by Application
- 5.1 Flu Shots Application Introduction
- 5.1.1 Avian Influenza Virus-A
- 5.1.2 Avian Influenza Virus-B
- 5.2 Global Flu Shots Sales Volume by Application
- 5.2.1 Global Flu Shots Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Flu Shots Sales Volume by Application (2020-2031)
- 5.2.3 Global Flu Shots Sales Volume Share by Application (2020-2031)
- 5.3 Global Flu Shots Sales Value by Application
- 5.3.1 Global Flu Shots Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Flu Shots Sales Value by Application (2020-2031)
- 5.3.3 Global Flu Shots Sales Value Share by Application (2020-2031)
- 6 Flu Shots Regional Sales and Value Analysis
- 6.1 Global Flu Shots Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Flu Shots Sales by Region (2020-2031)
- 6.2.1 Global Flu Shots Sales by Region: 2020-2025
- 6.2.2 Global Flu Shots Sales by Region (2026-2031)
- 6.3 Global Flu Shots Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Flu Shots Sales Value by Region (2020-2031)
- 6.4.1 Global Flu Shots Sales Value by Region: 2020-2025
- 6.4.2 Global Flu Shots Sales Value by Region (2026-2031)
- 6.5 Global Flu Shots Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Flu Shots Sales Value (2020-2031)
- 6.6.2 North America Flu Shots Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Flu Shots Sales Value (2020-2031)
- 6.7.2 Europe Flu Shots Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Flu Shots Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Flu Shots Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Flu Shots Sales Value (2020-2031)
- 6.9.2 South America Flu Shots Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Flu Shots Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Flu Shots Sales Value Share by Country, 2024 VS 2031
- 7 Flu Shots Country-level Sales and Value Analysis
- 7.1 Global Flu Shots Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Flu Shots Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Flu Shots Sales by Country (2020-2031)
- 7.3.1 Global Flu Shots Sales by Country (2020-2025)
- 7.3.2 Global Flu Shots Sales by Country (2026-2031)
- 7.4 Global Flu Shots Sales Value by Country (2020-2031)
- 7.4.1 Global Flu Shots Sales Value by Country (2020-2025)
- 7.4.2 Global Flu Shots Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Flu Shots Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Flu Shots Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Flu Shots Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Flu Shots Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Flu Shots Sales Value Growth Rate (2020-2031)
- 7.9.2 France Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Flu Shots Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Flu Shots Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Flu Shots Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Flu Shots Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Flu Shots Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Flu Shots Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Flu Shots Sales Value Growth Rate (2020-2031)
- 7.16.2 China Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Flu Shots Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Flu Shots Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Flu Shots Sales Value Growth Rate (2020-2031)
- 7.19.2 India Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Flu Shots Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Flu Shots Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Flu Shots Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Flu Shots Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Flu Shots Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Flu Shots Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Flu Shots Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Flu Shots Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Flu Shots Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Flu Shots Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Flu Shots Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Flu Shots Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Flu Shots Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Flu Shots Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Flu Shots Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Flu Shots Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 SANOFI
- 8.1.1 SANOFI Comapny Information
- 8.1.2 SANOFI Business Overview
- 8.1.3 SANOFI Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.1.4 SANOFI Flu Shots Product Portfolio
- 8.1.5 SANOFI Recent Developments
- 8.2 GSK
- 8.2.1 GSK Comapny Information
- 8.2.2 GSK Business Overview
- 8.2.3 GSK Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.2.4 GSK Flu Shots Product Portfolio
- 8.2.5 GSK Recent Developments
- 8.3 VAXTEC
- 8.3.1 VAXTEC Comapny Information
- 8.3.2 VAXTEC Business Overview
- 8.3.3 VAXTEC Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.3.4 VAXTEC Flu Shots Product Portfolio
- 8.3.5 VAXTEC Recent Developments
- 8.4 TIANYUAN BIO-PHARMA
- 8.4.1 TIANYUAN BIO-PHARMA Comapny Information
- 8.4.2 TIANYUAN BIO-PHARMA Business Overview
- 8.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
- 8.4.5 TIANYUAN BIO-PHARMA Recent Developments
- 8.5 SIOBP
- 8.5.1 SIOBP Comapny Information
- 8.5.2 SIOBP Business Overview
- 8.5.3 SIOBP Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.5.4 SIOBP Flu Shots Product Portfolio
- 8.5.5 SIOBP Recent Developments
- 8.6 SINOVAC
- 8.6.1 SINOVAC Comapny Information
- 8.6.2 SINOVAC Business Overview
- 8.6.3 SINOVAC Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.6.4 SINOVAC Flu Shots Product Portfolio
- 8.6.5 SINOVAC Recent Developments
- 8.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- 8.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Comapny Information
- 8.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
- 8.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
- 8.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
- 8.8 HUALAN BIO
- 8.8.1 HUALAN BIO Comapny Information
- 8.8.2 HUALAN BIO Business Overview
- 8.8.3 HUALAN BIO Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.8.4 HUALAN BIO Flu Shots Product Portfolio
- 8.8.5 HUALAN BIO Recent Developments
- 8.9 CHANGSHENG
- 8.9.1 CHANGSHENG Comapny Information
- 8.9.2 CHANGSHENG Business Overview
- 8.9.3 CHANGSHENG Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.9.4 CHANGSHENG Flu Shots Product Portfolio
- 8.9.5 CHANGSHENG Recent Developments
- 8.10 CCBIO
- 8.10.1 CCBIO Comapny Information
- 8.10.2 CCBIO Business Overview
- 8.10.3 CCBIO Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.10.4 CCBIO Flu Shots Product Portfolio
- 8.10.5 CCBIO Recent Developments
- 8.11 ALEPH BIOMEDICAL
- 8.11.1 ALEPH BIOMEDICAL Comapny Information
- 8.11.2 ALEPH BIOMEDICAL Business Overview
- 8.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Value and Gross Margin (2020-2025)
- 8.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
- 8.11.5 ALEPH BIOMEDICAL Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Flu Shots Value Chain Analysis
- 9.1.1 Flu Shots Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Flu Shots Sales Mode & Process
- 9.2 Flu Shots Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Flu Shots Distributors
- 9.2.3 Flu Shots Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


